Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Conbercept (Primary)
- Indications Choroidal neovascularisation; Polypoidal choroidal vasculopathy; Wet age-related macular degeneration
- Focus Pharmacogenomic; Therapeutic Use
- 28 Apr 2017 New trial record